Optometrists in Myrtle Beach, SC Accepting Medicare
46 Optometrists found. Showing 41 - 46
 Grand Strand Vision Services, Inc. Optometrist - Vision Therapy Medicare: Medicare Enrolled Practice Location: 4886 Socastee Blvd, Myrtle Beach, SC 29588 Phone: 843-293-1555 Fax: 843-293-8102 |
 Dr. Samuel J Singleton, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 350 Seaboard St, Myrtle Beach, SC 29577 Phone: 843-449-2020 |
Carolina Forest Family Eyecare, P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 3874 Renee Dr, Suite D, Myrtle Beach, SC 29579 Phone: 843-903-6262 Fax: 843-903-6228 |
Dr. Fouad S Allouch, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2703 N Kings Hwy, Myrtle Beach, SC 29577 Phone: 843-448-1596 Fax: 843-448-4793 |
Mills Vision Care, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 3013 Newcastle Loop, Myrtle Beach, SC 29588 Phone: 843-215-3000 Fax: 843-215-5310 |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1950 Mr Joe White Ave, Myrtle Beach, SC 29577 Phone: 843-353-5000 |
News Archive
New national standards issued for newborn screening
New national standards issued today will assist states to align their newborn screening programs with "the most up-to-date research, technology, laboratory and public health standards and practices."
Common opioid-based painkillers increase harmful side effects in people with dementia
Commonly-prescribed opioid-based painkillers led to harmful side effects tripling in people with dementia.
First Edition: September 9, 2011
Appeals courts have ruled on five challenges to the health law, and two more currently await appeals courts rulings. On Sept. 8, the 4th Circuit Court of Appeals ruled on two challenges to the health law, brought by the Commonwealth of Virginia and Liberty University, and in both cases they vacated the district court ruling and instructed the lower court to dismiss the challenges.
Aegera reports data from Phase 1 portion of combination AEG35156 Phase 1-2 study for primary liver cancer
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
Digital versions of standard molecular biology tool to detect common tumor-associated mutation in CSF
Massachusetts General Hospital (MGH) researchers and their colleagues have used digital versions of a standard molecular biology tool to detect a common tumor-associated mutation in the cerebrospinal fluid (CSF) of patients with brain tumors. In their report being published in the open-access journal Molecular Therapy - Nucleic Acids, the investigators describe using advanced forms of the gene-amplification technology polymerase chain reaction (PCR) to analyze bits of RNA carried in membrane-covered sacs called extracellular vesicles for the presence of a tumor-associated mutation in a gene called IDH1.
› Verified 9 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Optometrists
Podiatrists
Audiologists